Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01091168
Recruitment Status : Completed
First Posted : March 23, 2010
Last Update Posted : October 13, 2016
Information provided by (Responsible Party):
Pierre Fabre Medicament